KHK2375

· Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KHK2375, covering 2022-06-21 to 2022-06-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer [Phase 2]